HDAC2 and chronic obstructive pulmonary disease: Quanzhenyiqitang-treated serum significantly increased HDAC2 activity in AMs from rats with COPD; thus, the dynamic balance between histone acetyltransferases (HATs) and HDAC was adjusted and inflammation was ameliorated.